Eureka Globalstars Japan

28 Oct 2025 – 21 Jan 2026

Project cooperationUpdated on 20 November 2025

UK Women's Health Device Company Seeks Japanese Partners for Vaginal Drug-Delivery Platform Collaboration

Strategy/Finance at Calla Lily Clinical Care

London, United Kingdom

About

Calla Lily Clinical Care, a UK-based women's health medical device company, is seeking Japanese partners to collaborate on a Eureka GlobalStars Japan grant application.

What we offer:

We've developed a vaginal drug-delivery platform that is therapeutic-agnostic. Our platform can deliver hormones, live biotherapeutics, nutraceuticals, and microbiome therapies.

Who we're looking for:

We are specifically looking for Japanese startups, SMEs, research groups or academic institutes working in:

  • Fertility and reproductive health

  • Menopause treatments and nutraceuticals

  • Microbiome / LBP research

  • Women’s-health diagnostics or biomarkers

The Opportunity:

  • Co-develop products combining your therapeutic with our delivery device

  • Access funded R&D through Eureka GlobalStars (grants for both partners)

  • Leverage our proven IP (patents granted in Japan, US, Europe)

  • Enter Japanese and Asian markets together

Next Steps: Contact Precious Kilimo at pkilimo@callali.ly to discuss collaboration and joint application development.

Stage

  • Early

Type

  • Research
  • Technical

Organisation

Calla Lily Clinical Care

Startup

London, United Kingdom

Similar opportunities